Samal, Zuhara A.
HRN: 06-81-24 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/07/2025
11/14/2025
IV
600mg
QID
Diabetic Foot
Checking Initial Appropriateness
11/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/07/2025
11/14/2025
IV
4.5g
Q8h
DM Foot
Checking Initial Appropriateness